Search results
Benzene Exposure Linked to Acute Myeloid Leukemia, Aplastic Anemia, and Lymphomas | JD Supra
JD Supra· 4 days agoIf you have been diagnosed with acute myeloid leukemia but cannot figure out why, benzene may be responsible. Benzene, a chemical used in various industries ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoEHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress PR Newswire SUZHOU, China and ROCKVILLE, Md., May 15, 2024 SUZHOU, China and ROCKVILLE
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Rishi Gupta Sells 1,033,300 Shares of Stock
ETF DAILY NEWS· 6 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Rishi Gupta sold 1,033,300 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were ...
Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze
Market Watch· 6 days agoAlthough as it still has no drugs approved by the Food and Drug Administration, incremental updates...
What Is Immunophenotyping?
Healthline· 6 days agoImmunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases....
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoPRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures with
Quit Smoking For Better Health
Centers for Disease Control and Prevention· 6 days agoTiffany R. learned early in life that cigarettes cause premature death and disease: her mother died of smoking-related lung cancer when Tiffany was just...
Q2 2024 EPS Estimates for Tenax Therapeutics, Inc. Reduced by Analyst (NASDAQ:TENX)
ETF DAILY NEWS· 4 days agoTenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities research analysts at Roth Capital dropped their Q2 2024 earnings per share estimates for shares of Tenax Therapeutics in a research ...
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoVenetoclax has shown activity against the [anti-up total] protein Bcl-2 and works by neutralizing the protein's BH-3 domain. It is an approved treatment for chronic lymphocytic ...
Vanguard Personalized Indexing Management LLC Raises Position in Incyte Co. (NASDAQ:INCY)
ETF DAILY NEWS· 2 days agoVanguard Personalized Indexing Management LLC boosted its stake in Incyte Co. (NASDAQ:INCY – Free Report) by 30.4% during the fourth quarter, according to its most recent 13F filing with the ...
